Erlocip 100 mg
Available Dosages
| SKU | 1491 |
|---|---|
| Generic For | Tarceva |
| Strength | 100mg |
| Manufacturer | Cipla |
| Active Ingredient | Erlotinib |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 5.94 | US$ 178.20 | |||
|
|||||
Erlocip 100 mg – Affordable Tarceva Alternative for Lung Cancer
Erlocip 100 mg is a medication formulated for the management of metastatic non-small cell lung cancer and pancreatic cancer. It is meant to be given after chemotherapy. The medicine is used to disturb the growth and development of abnormal cells produced in the body. The active component of the medicine is Erlotinib, which falls into the category of drugs known as tyrosine kinase inhibitors. This drug work specifically on cancerous cells. It is a prescription medicine, which should be used under proper medical guidance and advice. Also, avoid sharing it with others, since they may be suffering from a problem that is not effectively treated with this anti-cancer agent.
What is Erlocip 100 mg used for?
Erlocip 100 mg is a widely used drug for the management of metastatic non small cell lung cancer and cancer of the pancreas. It can be used along with Gemcitabine, a chemotherapy drug used to treat patients with metastatic pancreatic cancer.
How does Erlocip work?
Erlocip comprises of Erlotinib, which acts by inhibiting the enzyme tyrosine kinase. It works by blocking the growth stimulation signals in cancer cells (abnormal cells). In this way, Erlocip decreased the chances of spreading of pancreatic and lung cancer.
Where to buy Erlocip online?
Purchase cheap Erlocip 100 mg for the treatment of pancreatic and lung cancer. You can place your order for Erlocip on premiumrxdrugs and get the product at an affordable rate.
What does Erlocip contain?
Each Erlocip tablet contains 100 mg of the active ingredient Erlotinib to prevent the growth of abnormal cells.
Effects of grapefruit juice
The medicine should not take along with grape juice as it may lead to severe adverse effects and can harm a cancer patient in many ways.
What medications interact with Erlocip?
The drugs that may interact with Erlocip 100 mg include:
- Corticosteroids such as prednisone
- Drugs that are used to lower stomach include omeprazole, famotidine, ranitidine, etc.
- Azole antifungals like itraconazole
- Macrolide antibiotics such as rifamycins, cimetidine, St. John’s wort, rifabutin
- Anti-seizure medicines like Carbamazepine
- HIV protease inhibitors including ritonavir
- MAO inhibitors including moclobemide, tranylcypromine, linezolid, methylene blue, rasagiline, procarbazine, selegiline, isocarboxazid
Also, avoid smoking as cigarette smoking decreases blood levels of Erlocip 100 mg. You should inform your physician if you smoke, or if you have recently stopped smoking.
This patient leaflet does not include all possible drugs that can interrupt with the working of Erlotinib. It’s better that you make a list of drugs that you use and share it with your physician when you whenever you visit your physician.
When should Erlocip not be used?
- The medicine should not be used in patients under 18 years of age.
- Its use is contraindicated in patients who are allergic to this anti-cancer agent or ingredients of the Erlocip.
The medicine is not always suitable for all patients. You are advised to consult your physician before taking the medicine if you are expecting a baby, breastfeeding, or trying to conceive. Also, inform if you are taking any other medicine during the treatment with Erlocip.
How should Erlocip be taken?
The medicine is supplied in the form of a tablet for oral administration. It must be taken either one hour before or two hours after having meals. Avoid taking it with heavy meals as it will delay the effect of the medicine in the body.
How long should you take Erlocip?
Keep on taking the medicine as long as it is recommended by your physician.
Missed dose of Erlocip
If you missed a dose of Erlocip, then no need to panic, just take it when you remember. Do not double up your Erlocip dose to recompense the missed one. It may lead to severe unwanted effects.
How should Erlocip be stored?
Store the tablets in an airtight container at controlled room temperature. Keep it away from high temperature, moisture, and wet places. Keep it away from the access of children and pets. Also, do not freeze the tablets.
What are the side effects of Erlocip?
You need to get immediate medical attention if you experience signs of allergic reactions such as swelling of your face, throat, or tongue, trouble breathing, and hives.
Some other side effects that require emergency medical help are stated below:
- Wheezing
- Shortness of breath
- Sudden chest pain or discomfort
- Heart attack symptoms like Pain in the chest or pressure, sweating, nausea, or pain spreading to your shoulder and jaw.
- Signs of a stroke include a severe headache, vision problem, blurred vision, sudden numbness or weakness, and the problem with balance.
What is Erlotinib and what condition does it treat?
Erlotinib is a targeted cancer therapy medication, sold under the brand name Erlocip 100 mg, primarily used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. This tyrosine kinase inhibitor works by blocking specific proteins that fuel cancer cell growth. Erlotinib is particularly effective for patients whose tumors have certain genetic mutations, especially EGFR (epidermal growth factor receptor) mutations. Oncologists prescribe this oral anticancer medicine as part of comprehensive treatment plans, often after other therapies have been tried or alongside chemotherapy for pancreatic cancer patients.
How does Erlotinib work in the body?
Erlotinib functions as an EGFR tyrosine kinase inhibitor, blocking signals that tell cancer cells to multiply and spread. Erlocip 100 mg specifically targets the epidermal growth factor receptor protein found on cancer cell surfaces. By binding to this receptor, the medication prevents the cancer cells from receiving growth signals they need to survive and divide. This targeted approach means erlotinib attacks cancer cells more precisely than traditional chemotherapy, which affects both healthy and cancerous cells. The result is slowed tumor progression in non-small cell lung cancer and pancreatic cancer patients with specific genetic markers.
How long does Erlocip 100 mg take to work?
Erlocip 100 mg begins working within hours of taking the tablet, as erlotinib quickly enters your bloodstream and starts blocking cancer cell signals. However, measurable clinical responses typically take several weeks to become apparent on imaging scans. Most oncologists evaluate treatment effectiveness after 6-8 weeks through CT scans or other monitoring methods. Some lung cancer patients notice symptom improvements like easier breathing or reduced coughing within the first month. Response times vary significantly based on tumor type, genetic profile, and individual patient factors. This targeted cancer medication requires consistent daily use to maintain therapeutic levels and continue suppressing tumor growth.
When and how should I take Erlocip 100 mg?
Take Erlocip 100 mg on an empty stomach, at least one hour before eating or two hours after meals, as food significantly reduces erlotinib absorption. Swallow the tablet whole with water at the same time each day to maintain consistent blood levels of this tyrosine kinase inhibitor. Most patients choose morning dosing to establish a routine. Avoid grapefruit and grapefruit juice, which can interfere with how your body processes this lung cancer medication. If you miss a dose and it's more than 12 hours until your next scheduled dose, take it immediately; otherwise, skip it and resume your normal schedule.
Is Erlocip 100 mg safe for long-term use?
Erlocip 100 mg is designed for long-term continuous use in managing non-small cell lung cancer and pancreatic cancer, with many patients taking erlotinib for months or years. Clinical trials have demonstrated that extended treatment is generally well-tolerated when properly monitored. Oncologists conduct regular blood tests to check liver function, kidney health, and overall response, adjusting treatment as needed. While side effects like skin rash and diarrhea may persist, they often become manageable over time with supportive care. The safety profile of this targeted therapy medication makes long-term administration feasible for controlling cancer progression in responsive patients.
Can I take Erlocip 100 mg with other medicines?
Erlocip 100 mg can interact with numerous medications, making medical supervision essential when combining treatments. Drugs that reduce stomach acid (like omeprazole or ranitidine) significantly decrease erlotinib absorption and should be avoided or timed carefully. Blood thinners like warfarin may require dose adjustments, as this tyrosine kinase inhibitor can affect clotting factors. Antibiotics, antifungals, and seizure medications can either increase or decrease erlotinib levels in your blood. St. John's Wort and certain herbal supplements should be avoided. Always inform your oncologist and pharmacist about all medications, supplements, and over-the-counter products you're taking with this cancer therapy.
How does Erlocip 100 mg compare to similar medicines in its class?
Erlocip 100 mg (erlotinib) belongs to the EGFR tyrosine kinase inhibitor class alongside medications like gefitinib and afatinib for treating lung cancer. Erlotinib offers once-daily dosing convenience and has extensive clinical data supporting its effectiveness in EGFR-mutated non-small cell lung cancer. Compared to newer-generation inhibitors like osimertinib, this first-generation targeted therapy has a longer track record and lower cost, though it may be less effective against certain resistance mutations. Erlotinib's side effect profile is similar to other drugs in this anticancer medication class, with rash and diarrhea being common across all EGFR inhibitors.
Is the generic Erlotinib as effective as branded versions?
Generic erlotinib, including Erlocip 100 mg, is bioequivalent to branded Tarceva, meaning it delivers the same active ingredient at the same strength and absorption rate. Regulatory authorities in the USA, UK, Canada, and Australia require generic cancer medications to meet strict standards proving they work identically to original branded versions. Clinical outcomes for non-small cell lung cancer patients using generic erlotinib match those achieved with branded formulations. The tyrosine kinase inhibitor molecule is identical; only inactive ingredients may differ slightly. Generic versions offer substantial cost savings while maintaining the same therapeutic effectiveness, making this targeted cancer therapy more accessible worldwide.
Why do patients choose PremiumRxDrugs for Erlocip 100 mg?
Patients select PremiumRxDrugs for Erlocip 100 mg because as an established pharmacy, we combine affordability with reliability for long-term cancer treatment needs. The pharmacy offers manufacturer-sourced erlotinib at competitive prices, making this essential tyrosine kinase inhibitor more accessible for patients facing ongoing medication costs. Easy reorder systems simplify prescription management for those taking this lung cancer medication continuously. Discreet international shipping reaches patients in the USA, UK, Australia, Canada, and beyond, with free shipping options available. After more than ten years serving the global community, PremiumRxDrugs has built trust through consistent delivery of authentic anticancer medications and responsive customer support.
What are the common side effects of Erlotinib?
Erlotinib commonly causes an acne-like skin rash, typically appearing on the face, chest, and back within the first few weeks of treatment. Diarrhea affects many patients taking this EGFR inhibitor, ranging from mild to moderate severity. Other frequent side effects include dry skin, fatigue, loss of appetite, and mouth sores. Some patients experience eye irritation or conjunctivitis. Less common but more serious reactions include severe skin reactions, liver problems, and lung inflammation. The skin rash, while uncomfortable, often indicates the medication is working effectively. Most side effects are manageable with supportive treatments, and many diminish as your body adjusts to this targeted cancer therapy.
Who should avoid taking Erlotinib?
Erlotinib should be avoided by pregnant or breastfeeding women, as this tyrosine kinase inhibitor can harm developing babies. Patients with severe liver disease require careful evaluation before starting this medication, as the liver processes erlotinib and damage can occur. Those with a history of serious lung conditions like interstitial lung disease face higher risks of potentially fatal complications. People with known hypersensitivity to erlotinib or its ingredients should not take this cancer medication. Patients taking certain medications that strongly interact with this EGFR inhibitor may need alternative treatments. Very young children typically aren't prescribed erlotinib due to limited safety data in pediatric populations.
Login
Sign Up
Login
Sign Up